Search Results 741-750 of 17067 for monoclonal antibody
... monoclonal antibody or kinase inhibitor. Participation in clinical trials ... Use of any neutralizing monoclonal antibodies such as bamlanivimab (LY ...
Monoclonal antibodies: at least 3 half-lives must have elapsed since prior therapy that included a monoclonal antibody; Radiation therapy (RT): >= 2 weeks ...
This system detects heavy metal-labeled antibodies in the time-of-flight chamber of an inductively coupled mass spectrometer (ICP-MS). These capabilities allow ...
Prior monoclonal antibody within 4 weeks prior to study Day 1; Prior Chemotherapy, targeted small molecular therapy, or radiation therapy within 2 weeks ...
... monoclonal antibodies, alpha-4 beta-7 integrin inhibiting monoclonal antibody, interleukin 12/23 inhibiting monoclonal antibody, JAK inhibitors.
Other monoclonal antibodies, antibody-drug conjugates, or radioimmunoconjugates: 4 weeks (2 weeks with documented disease progression);; T-cell or other cell ...
... Antibody Responses Predict Protection against SARS ... Production and flow cytometric application of a monoclonal anti-glucocorticoid receptor antibody.
Any patients who received a desensitization therapy including any monoclonal antibodies, plasmapheresis, and/or splenectomy; Inability to understand and sign ...
Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...
Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.